Pathway

1.4K posts

Pathway banner
Pathway

Pathway

@PathwayMedical

Medical knowledge at your fingertips. Available on iOS, Android and web.

Katılım Şubat 2018
5.5K Takip Edilen12.9K Takipçiler
Pathway
Pathway@PathwayMedical·
Hey Nishant, sorry to hear that’s been your experience. The response in your screenshot doesn’t look fully loaded - did it stop there? Please reach out to us at support@pathway.md and we’ll help sort it out. We really appreciate the feedback and want to make sure you’re getting the best experience with Pathway.
English
0
0
0
73
Pathway retweetledi
Jon Hershon
Jon Hershon@jonathanhershon·
Having the chance to work alongside Jeff, who has shaped how clinicians connect, learn, and deliver care for decades, has been a privilege. Proud that Pathway is now part of this story.
Newsweek@Newsweek

Jeff Tangney's dorm-room project grew into a $13.8 billion enterprise, beloved by physicians. He sat down with Newsweek to share how he did it. #Echobox=1758652842" target="_blank" rel="nofollow noopener">newsweek.com/how-doximity-b…

English
0
2
6
1.7K
Pathway retweetledi
Jon Hershon
Jon Hershon@jonathanhershon·
Thrilled to share that @PathwayMedical has been acquired by @doximity. Seven years ago, @LouisMullie, Chris, and I set out with a simple vision: use technology to make it easier for clinicians to care for patients. Today, Pathway is in the hands of hundreds of thousands of healthcare professionals, helping them answer millions of clinical questions. That mission is what first connected me with Jeff Tangney, Doximity’s co-founder and CEO. Jeff previously co-founded Epocrates, the first medical app for the iPhone, and helped define mobile clinical reference for a generation of providers. That same spirit drives Doximity today, now home to over 80% of U.S. physicians and deeply embedded in how healthcare professionals connect, stay informed, and deliver care. Bringing Pathway and Doximity together means accelerating our roadmap and putting the next generation of evidence-based clinical reference in the hands of millions, for free. I'm incredibly excited to build alongside the talented Doximity team to make that vision real. None of this would have been possible without a brilliant team who made the mission their own, and the mentors, friends, investors, and partners who believed in us. Grateful for the last chapter, and energized for what's ahead. We're just getting started.
Pathway@PathwayMedical

Today marks an exciting new chapter for Pathway: we’re joining @doximity! Over the past 7 years, our physician-led team has built one of the largest structured datasets in medicine, purpose-built for AI. With it, we’ve delivered trusted, evidence-based clinical reference to hundreds of thousands of clinicians, including thousands of whom subscribe to our premium product. Now, with Doximity, one of the most trusted platforms in healthcare, we’ll bring that same AI-powered clinical reference experience to millions of clinicians for free, built directly into the tools they already love and use at the point of care. Learn more here: pathway.md/blog/pathway-i…

English
14
8
52
8.1K
Pathway retweetledi
Pathway
Pathway@PathwayMedical·
Today marks an exciting new chapter for Pathway: we’re joining @doximity! Over the past 7 years, our physician-led team has built one of the largest structured datasets in medicine, purpose-built for AI. With it, we’ve delivered trusted, evidence-based clinical reference to hundreds of thousands of clinicians, including thousands of whom subscribe to our premium product. Now, with Doximity, one of the most trusted platforms in healthcare, we’ll bring that same AI-powered clinical reference experience to millions of clinicians for free, built directly into the tools they already love and use at the point of care. Learn more here: pathway.md/blog/pathway-i…
GIF
English
0
2
18
8.9K
Pathway
Pathway@PathwayMedical·
#AskPathway — What is the most appropriate early targeted antimicrobial regimen for this patient? A. Ceftriaxone 2 g IV q12hrs B. Meropenem 2 g IV q8hrs, plus consideration of intraventricular amikacin C. Vancomycin IV plus ampicillin/sulbactam IV D. Levofloxacin IV monotherapy pathway.md/ai/history/2a4…
Pathway tweet media
English
0
0
4
844
Pathway
Pathway@PathwayMedical·
#AskPathway — What are the safety considerations for using vaginal estrogen for genitourinary syndrome of menopause in women with a history of breast cancer? pathway.md/ai/history/ac6…
Pathway tweet media
English
0
0
2
526